
ResMed Inc. (RMD)
đ Dividend Highlights
Previous Payout History
51 payouts shownPay Date | Amount Per Share | Change vs Previous |
---|---|---|
March 20, 2025 | $0.53 | - |
December 12, 2024 | $0.53 | - |
September 19, 2024 | $0.53 | â˛10.42% |
June 13, 2024 | $0.48 | - |
March 14, 2024 | $0.48 | - |
December 14, 2023 | $0.48 | - |
September 21, 2023 | $0.48 | â˛9.09% |
June 15, 2023 | $0.44 | - |
March 16, 2023 | $0.44 | - |
December 15, 2022 | $0.44 | - |
September 22, 2022 | $0.44 | â˛4.76% |
June 16, 2022 | $0.42 | - |
March 17, 2022 | $0.42 | - |
December 16, 2021 | $0.42 | - |
September 23, 2021 | $0.42 | â˛7.69% |
June 17, 2021 | $0.39 | - |
March 18, 2021 | $0.39 | - |
December 17, 2020 | $0.39 | - |
September 24, 2020 | $0.39 | - |
June 18, 2020 | $0.39 | - |
March 19, 2020 | $0.39 | - |
December 12, 2019 | $0.39 | - |
September 19, 2019 | $0.39 | â˛5.41% |
June 13, 2019 | $0.37 | - |
March 14, 2019 | $0.37 | - |
December 13, 2018 | $0.37 | - |
September 20, 2018 | $0.37 | â˛5.71% |
June 14, 2018 | $0.35 | - |
March 15, 2018 | $0.35 | - |
December 14, 2017 | $0.35 | - |
September 21, 2017 | $0.35 | â˛6.06% |
June 15, 2017 | $0.33 | - |
March 16, 2017 | $0.33 | - |
December 15, 2016 | $0.33 | - |
September 22, 2016 | $0.33 | â˛10.00% |
June 16, 2016 | $0.30 | - |
March 17, 2016 | $0.30 | - |
December 17, 2015 | $0.30 | - |
September 17, 2015 | $0.30 | â˛7.14% |
June 18, 2015 | $0.28 | - |
March 19, 2015 | $0.28 | - |
December 18, 2014 | $0.28 | - |
September 18, 2014 | $0.28 | â˛12.00% |
June 17, 2014 | $0.25 | - |
March 19, 2014 | $0.25 | - |
December 18, 2013 | $0.25 | - |
September 17, 2013 | $0.25 | â˛47.06% |
June 18, 2013 | $0.17 | - |
March 19, 2013 | $0.17 | - |
December 18, 2012 | $0.17 | - |
September 28, 2012 | $0.17 |
Overall Dividend Trend
Dividend per share has changed by +211.76% over the past 13 years (comparing first and last payout shown).
About ResMed Inc.
ResMed Inc. is a global leader in digital health and cloud-connected devices for people with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic respiratory conditions. Founded in 1989 by Dr. Peter Farrell, the company is headquartered in San Diego, California. As of the latest updates, Mick Farrell, the son of the founder, serves as the CEO. ResMed is renowned for its innovative products, including sleep apnea devices known as CPAP machines, and is actively expanding its offerings in digital health solutions, which emphasize patient monitoring and engagement. The company has a strong global presence, operating in over 140 countries. For fiscal year 2022, ResMed reported revenues of approximately $3.6 billion, underscoring its robust growth and significant impact on the healthcare industry. The company is committed to improving patient outcomes and enhancing the quality of life through cutting-edge technology and a deep focus on research and development.
Dividend data last updated: Sat, 19 Apr 2025 05:23:05 GMT. Financial data is indicative and provided for informational purposes only.